Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer

Yassene Mohammed, Bart J. Van Vlijmen, Juncong Yang, Andrew J. Percy, Magnus Palmblad, Christoph H. Borchers, Frits R. Rosendaal

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


The plasma levels of pro- and anticoagulant proteins are important markers for venous thrombosis (VT) risk and can be affected by both genetic and acquired factors, including cancer. Generally, these markers are measured using activity- or antibody-based assays. Targeted proteomics with stable-isotope-labeled internal standards has proven adept at the rapid, multiplex, and precise quantification of proteins in complex biological samples such as plasma. We used liquid chromatography coupled to multiple reaction monitoring (MRM) mass spectrometry to evaluate the concentrations of 31 coagulation- and fibrinolysis-related proteins in plasma from 25 healthy controls, 25 patients with VT, and 25 patients with VT who were also diagnosed with cancer. The concentration level of 1 to 3 proteotypic peptides per protein was determined, and all samples were previously characterized using traditional antibody- or activity-based methods. When comparing the conventional and the MRM strategies, the mean Pearson correlation for the 13 proteins (covered by 36 target peptides) shared between the 2 approaches was 0.77, indicating a good correlation. Additionally, MRM offers higher sensitivity (mean regression slope, 0.81), higher multiplicity in a single run, and good ability to leverage all measurements to discriminate groups using unsupervised clustering, which identified vitamin K antagonist users as well as patients with VT and cancer. The data collected using MRM show that the combination of coagulation factor levels yields signature information on VT and cancer, which was not obvious from a single measurement. These results encourage the further validation and investigation of MRM in profiling protein signature of disease.

Original languageEnglish
Pages (from-to)1080-1087
Number of pages8
JournalBlood Advances
Issue number15
Publication statusPublished - 27 Jun 2017
Externally publishedYes


Dive into the research topics of 'Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer'. Together they form a unique fingerprint.

Cite this